Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Chemical Biology|May 12, 2026
MEK interactions tune RAF kinase sensitivity to conformation-selective inhibitionEthan G Stoddard, B Gayani K Perera, Linglan Fang, et al.
Journal of the American Chemical Society|October 24, 2012
Affinity-based probes based on type II kinase inhibitorsPratistha Ranjitkar, B Gayani K Perera, Danielle L Swaney, et al.
Nature Chemical Biology|October 23, 2012
Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitorsLikun Wang, B Gayani K Perera, Sanjay B Hari, et al.
Nature Chemical Biology|September 24, 2021
ATP-competitive partial antagonists of the IRE1α RNase segregate outputs of the UPRHannah C Feldman, Rajarshi Ghosh, Vincent C Auyeung, et al.
ACS Medicinal Chemistry Letters|December 1, 2010
Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondiiRyan C Murphy, Kayode K Ojo, Eric T Larson, et al.
Journal of Medicinal Chemistry|February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activitySteven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
Journal of Medicinal Chemistry|February 29, 2012
Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1Eric T Larson, Kayode K Ojo, Ryan C Murphy, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C Sprenger, et al.
Molecular Cancer Therapeutics|March 20, 2024
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C T Sprenger, et al.
Pageof 2